Baillie Gifford & Co
CRSP icon

Baillie Gifford & Co’s CRISPR Therapeutics CRSP Stock Holding History

Baillie Gifford & Co’s Portfolio CRSP Stock Details CRSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
2024
Q3 		$17.1M Sell
2024
Q2 		$21.9M Buy
2024
Q1 		$27M Sell
2023
Q4 		$26.5M Sell
2023
Q3 		$20M Buy
2023
Q2 		$13.7M Sell
2023
Q1 		$11.9M Hold
2022
Q4 		$10.7M Sell
2022
Q3 		$18.9M Buy